News & Research
-
Hepatocellular carcinoma therapy finds a channel on the radio
HCC is the main type of liver cancer which has a very poor prognosis. Finding alternative therapeutic approaches for these patients is imperative.
-
Tumour-specific AM RF EMF induce differentiation of hepatocellular carcinoma via targeting Cav3.2 T-type voltage-gated calcium channels and calcium influx
Administration of amplitude modulated 27·12 MHz radiofrequency electromagnetic fields (AM RF EMF) by means of a spoon-shaped applicator placed on the patient's tongue is a newly approved treatment for advanced hepatocellular carcinoma (HCC).
-
Ca2+ and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF
Study of a novel therapy for brain metastases that delivers athermal radiofrequency electromagnetic fields that are amplitude-modulated at breast cancer specific frequencies (BCF).
-
Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies
We have developed noninvasive biofeedback examination devices and techniques and discovered that patients with the same tumor type exhibit biofeedback responses to the same, precise frequencies.
-
Cancer cell proliferation is inhibited by specific modulation frequencies
These findings uncover a novel mechanism controlling the growth of cancer cells at specific modulation frequencies without affecting normal tissues, which may have broad implications in oncology.
-
Amplitude-modulated electromagnetic fields for treatment of cancer
Because in vitro studies suggest that low levels of electromagnetic fields may modify cancer cell growth, we hypothesized that systemic delivery of a combination of tumor-specific frequencies may have a therapeutic effect.